Telix Pharmaceuticals Ltd. Securities Class Action Lawsuit: Deadline Tomorrow for Lead Plaintiff to Move Court

Rosen Law Firm reminds Telix Pharmaceuticals investors to secure counsel before the January 9 deadline in a securities class action. Investors who purchased Telix securities between February 21, 2025 and August 28, 2025 may be entitled to compensation. To join the class action, visit https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. at 866-767-3653. The Rosen Law Firm has experience in securities class actions and shareholder derivative litigation, and has recovered hundreds of millions of dollars for investors.